Occasionally, investors will find themselves looking at an underperforming portfolio. Sometimes, this may be a case of the portfolio not being properly diversified. Investing too heavily in one stock or sector can cause the balance to tip the wrong way, especially if the overall market takes a downturn. Although there is no one way to protect against tough economic conditions, setting up the portfolio to withstand a prolonged sluggish period can help ease the mind of the investor when markets are in turmoil. Maintaining a large mix of different types of stocks may help the portfolio survive through rough patches down the line.   

Taking a look at the Donchian Channels indicator on shares of bluebird bio, Inc. (NASDAQ:BLUE), we note that the 20 day lower band is 95.36. The 20 day upper band is 106.52. This indicator was created by Richard Donchian, and traders follow these channels to help identify potential trading signals.

There are a number of different pivot points that traders can use when conducting stock analysis. Pivot points can be useful for traders looking to establish trading entry and exit points. Focusing on some popular one month pivots, we see that the Woodie pivot is currently at 99.83875. The Woodie support 1 pivot is 95.5625, and the Woodie resistance 1 pivot is 103.5175. The Camarilla one month pivot is presently 99.87166667. The one month Classic pivot is 99.87166667 and the Classic resistance 1 is 103.5833333 while the Classic support 1 pivot is measured at 95.62833333.

Traders will take note of the 20 day Chaikin Money Flow indicator that is now at 0.21456088 for bluebird bio, Inc. (NASDAQ:BLUE). The value of this indicator will fluctuate between 1 and -1. Traders may be watching when the CMF crosses zero. This cross might point to a bullish or bearish price reversal depending on which way it is moving crossing the zero line.

Technical traders have many tools at their disposal when conducting stock research. One of those tools is the Exponential Moving Average or EMA. The EMA is similar to the simple moving average, but more weight is put on the newest data. Let’s look at some different EMA levels:

10 day Exponential Moving Average: 102.1852986
20 day Exponential Moving Average: 102.6527109
30 day Exponential Moving Average: 104.4272422
50 day Exponential Moving Average: 108.4794586
100 day Exponential Moving Average: 115.4856388
200 day Exponential Moving Average: 122.3575447

Tracking some stock ratings, we can see that the stock’s Moving Average Rating is currently pointing to a “Buy”. Traders may be monitoring many different indicators in order to get a grasp of where the stock may be moving in the near future. Taking a look at the Oscillators rating, we note that the reading is pointing to a “Buy”.

Following trading action on shares of bluebird bio, Inc. (NASDAQ:BLUE), we see that the stock has moved 3.65 since the opening price of 102.64. So far, the stock has reached a high of 106.52 and dipped to a low of 102.19. The consensus rating on the stock is currently Buy, and today’s volume has been measured around 205146.

The Awesome Oscillator reading is currently -2.45988294. Technical traders will watch the AO especially when it crosses above or below the zero line. A move above the line may signal a bullish scenario. A move below the zero line may indicate a bearish selling opportunity. The AO may prove to be a valuable tool for many momentum traders.

Investors are constantly looking for ways to find success in the stock market. Figuring out what stocks to buy can be tough. With so many different names to choose from, the task can seem quite overwhelming at times. Many investors will opt to go with a mix of growth and value stocks. Investors looking to capitalize on shorter-term price movements may have a completely different game plan than those who are looking to fin stocks to hold onto for the longer-term. Finding quality stocks that match the individual’s criteria may take a lot of effort and dedication, but it may be well worth it for the long-term success of the portfolio.      

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.